Source: Annual Congress 2013 –COPD: new markers of diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. García, R. Del Pozo, N. Coll, C. Bonjoch, I. Crespo, M. Musri, O. Tura, V. I. Peinado, J. A. Barberà (Barcelona, Spain). Increased circulating endothelial microparticles in COPD. Eur Respir J 2013; 42: Suppl. 57, 612

Member's Comments

No comment yet.

Related content which might interest you: Endothelial microparticles in sputum of COPD patients: A potential biomarker of disease Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Increased circulating alveolar epithelial microparticles in COPD patients Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Alterations of the soluble proteome of airway epithelial cells in COPD Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome) Year: 2013 IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 TNFalpha release by monocyte-derived macrophages at stable and exacerbation states in COPD Source: International Congress 2014 – COPD physiopathology Year: 2014 Increased levels of circulating endothelial progenitor cells during exacerbations of COPD Source: Annual Congress 2007 - Biomarkers and assessment of COPD Year: 2007 Increased serum level of apelin in chronic obstructive pulmonary disease Source: International Congress 2015 – COPD: interesting notes Year: 2015 Determinants of endothelial function in patients with COPD Source: Eur Respir J 2013; 42: 1194-1204 Year: 2013 Increased circulating fibrocytes and their capacity of proliferation and differentiation in clinically unstable patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Relationship of monocyte-derived macrophage phagocytosis to exacerbation susceptibility in stable COPD Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities Year: 2014 Expression of vascular remodeling markers in relation to bradykinin receptors in asthma and COPD Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases Year: 2013 Presence of progranulin in airway inflammation associated with COPD Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Circulating levels of IGF-I and IGFBP-3 in patients with COPD Source: International Congress 2015 – COPD: notable points Year: 2015 Distribution of blood eosinophil in COPD patients Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014 Production of proinflammation cytokines and mean pulmonary arterial pressure in COPD Source: Annual Congress 2013 –The vulnerable patient and ageing cells Year: 2013 Relationship between monocyte-derived macrophage phagocytosis and airway inflammation in stable COPD Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Prevalence and trafficking of circulating fibrocytes in smoking-related fibrogenic lung diseases Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Serum levels of RAAS components in COPD Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Expression of HLA-DR in circulating polymorphonuclear neutrophils of COPD patients Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Plasma surfactant protein D (SP-D) and nutritive status in patients with COPD Source: Annual Congress 2013 –COPD treatment and others Year: 2013